Saccharomyces cerevisiae Dap1p, a Novel DNA Damage Response Protein Related to the Mammalian Membrane-Associated Progesterone Receptor by Hand, R. A. et al.
EUKARYOTIC CELL, Apr. 2003, p. 306–317 Vol. 2, No. 2
1535-9778/03/$08.000 DOI: 10.1128/EC.2.2.306–317.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Saccharomyces cerevisiae Dap1p, a Novel DNA Damage Response
Protein Related to the Mammalian Membrane-Associated
Progesterone Receptor
Randal A. Hand,1 Nan Jia,2 Martin Bard,2 and Rolf J. Craven1*
Department of Surgery, Division of Surgical Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina,
Chapel Hill, North Carolina 27599,1 and Department of Biology, Indiana University-Purdue University at Indianapolis,
Indianapolis, Indiana 462022
Received 3 September 2002/Accepted 23 December 2002
The response to damage is crucial for cellular survival, and eukaryotic cells require a broad array of proteins
for an intact damage response. We have found that the YPL170W (DAP1 [for damage response protein related
to membrane-associated progesterone receptors]) gene is required for growth in the presence of the methyl-
ating agent methyl methanesulfonate (MMS). The DAP1 open reading frame shares homology with a broadly
conserved family of membrane-associated progesterone receptors (MAPRs). Deletion of DAP1 leads to sensi-
tivity to MMS, elongated telomeres, loss of mitochondrial function, and partial arrest in sterol synthesis.
Sensitivity of dap1 strains to MMS is not due to loss of damage checkpoints. Instead, dap1 cells are arrested
as unbudded cells after MMS treatment, suggesting that Dap1p is required for cell cycle progression following
damage. Dap1p also directs resistance to itraconazole and fluconazole, inhibitors of sterol synthesis. We have
found that dap1 cells have slightly decreased levels of ergosterol but increased levels of the ergosterol
intermediates squalene and lanosterol, indicating that dap1 cells have a partial defect in sterol synthesis. This
is the first evidence linking a MAPR family member to sterol regulation or the response to damage, and these
functions are probably conserved in a variety of eukaryotes.
Eukaryotic cells are constantly exposed to exogenous and
endogenous damage. Cells respond to DNA damage by delay-
ing cell cycle progression (27), repairing the damage, and ac-
tivating or repressing transcription of a number of genes (19,
28). Mutants that are unable to activate the checkpoint path-
way continue to replicate damaged DNA and die (56). Check-
point proteins include the protein kinase Mec1p (1, 34, 40, 57)
and Rad9p (56). Some yeast damage repair mutants have a
functioning checkpoint response and are capable of delaying
the cell cycle but cannot repair the damaged lesion. In general,
yeast DNA repair mutants fall into three categories: mutants
affected in nucleotide excision repair, postreplication repair,
and recombinational repair (18).
Yeast requires a large number of processes to respond to
damage. Diploid yeast contains 130 nonessential genes that are
required for the response to ionizing radiation, and 100 of
these genes are required for the response to methyl methane-
sulfonate (MMS) (3). The total number of genes required for
the response to MMS is not known, and it is not clear which of
the radiation-sensitive diploids are sensitive as haploids. In
addition to proteins regulating the damage checkpoint and
recombinational repair, diploid yeasts require proteins direct-
ing replication, chromatin silencing, and mitotic chromosome
transmission for the response to MMS (3). Genes with less-
direct roles in DNA metabolism are also required for the
response to MMS, including genes encoding the nuclear pore
complex; vacuolar, Golgi, and endocytosis components; and
members of the ubiquitin degradation pathway and genes reg-
ulating transcription and RNA metabolism (3). Finally, dele-
tion of the ERG3 gene, encoding C-5 sterol desaturase, leads
to MMS sensitivity, and erg28 (17) and arv1 (for ARE2 re-
quired for viability) (53) strains are sensitive to a lesser extent
(3). Thus, the response to ionizing radiation and MMS is com-
plex and requires the function of a number of genes, including
some genes that function in sterol synthesis.
In yeast, several proteins that regulate the DNA damage
response are also required for telomere length maintenance
(reviewed in reference 4). Damage repair proteins probably
serve protective functions for telomeres, distinguishing them
from a double-stranded DNA break. Ku70p localizes to telo-
meres in the absence of damage and then translocates to sites
of damage following double-stranded DNA breaks (35, 36, 38).
The telomere binding proteins Sir3p, Sir4p, and Rap1p also
diffuse from the telomere after damage. Following transloca-
tion from the telomere, these proteins probably serve to cap
broken DNA ends and block replication and transcription in
the DNA adjacent to the break, facilitating the processing and
repair of these regions. A large number of proteins that con-
tribute to checkpoint or damage repair also regulate telomere
length, including members of the Mre11p-Rad50p-Xrs2p com-
plex (5), Mec1p (43), Mec3p (6), Rad27p (41), and Tel1p (21,
33).
We have searched for novel yeast genes that regulate the
damage response. The murine 25-Dx protein is induced fol-
lowing exposure of the carcinogen 2,3,7,8-tetrachloro-p-dioxin,
suggesting a role in the response to cellular stress and in
carcinogenesis (46). 25-Dx is part of a highly conserved family
of proteins that is collectively called the membrane-associated
progesterone receptor (MAPR) family. The porcine MAPR
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binds to progesterone and was isolated from liver membrane
fractions (14, 37). However, the biological function of MAPRs
in progesterone signaling is unknown.
The yeast open reading frame YPL170W encodes a protein
that is part of the MAPR family (Fig. 1). The predicted protein
product from the YPL170W open reading frame shares ho-
mology throughout its coding sequence with its human and
rodent counterparts (Fig. 1A) and has a region identical to
proteins from a broad variety of organisms, including Arabi-
dopsis thaliana and Schizosaccharomyces pombe (Fig. 1B).
Many of these proteins are similar in molecular weight and
contain the homologous region near the center of the coding
sequence (Fig. 1C).
Because of the role of 25-Dx in carcinogenesis, we deleted
the YPL170W open reading frame and have characterized the
phenotypes of the mutant strain. We have found that the phe-
notypes of the YPL170W strain are pleiotropic, affecting
growth in response to damage, telomere length, and sterol
regulation. Our results are the first genetic analysis of a MAPR
family member and indicate new roles for these proteins in the
damage response and cellular metabolism.
MATERIALS AND METHODS
Yeast strains and growth conditions. All strains were isogenic with W303
(leu2-3,112 his3-11,15 ura3-1 ade2-1 trp1-1 can1-100 rad5-535) (52) except for the
alterations described in Table 1. In most of the strains, the rad5-535 allele was
replaced with the wild-type RAD5 gene by crossing and tested by PCR as
described previously (9). In some strains, the type X subtelomeric repeat element
on the left telomere of chromosome XV was replaced with URA3 (designated
XVL-TEL-URA3) as described previously (8).
The DAP1 gene was replaced with the LEU2 gene by a one-step transplace-
FIG. 1. DAP1 is homologous to the MAPR family of proteins. (A) Identity between YPL170W/Dap1p (YPL) and the full-length rat and human
MAPR family members, 25-Dx and Hpr6.6, respectively. Identical residues are indicated by a black background. (B) Identity in the most highly
conserved region between YPL170W/Dap1p and related proteins from rat (rat 25-Dx), mouse (mouse 25-Dx), humans (Hpr6.6 and Dg6), fission
yeast (Z99126), and Arabidopsis (AF153283). (C) List of YPL170W/Dap1p and related proteins along with the total amino acids (aa) of the
predicted proteins and the corresponding amino acids of each protein that share the greatest identity with Dap1p (indicated by shading in panel
B). A schematic diagram of each protein is to the right of the list, with the region of homology indicated by a dark box.
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ment. The LEU2 gene was amplified from plasmid pRS305 (49) by using the
primers DAP1-KOF and DAP1-KOR, so that the PCR product contained the
entire LEU2 gene with flanking homology to DAP1. Strains were grown at 30°C
in yeast extract-peptone-dextrose (YPD) or synthetic media (22). All primer
sequences are available on request.
All genetic manipulations were performed essentially as described previously
(22). The haploid strains used in these studies were primarily derivatives of
diploid strains. The diploids were constructed by crossing the indicated strains
(genotypes are listed in Table 1), as follows: RCY93 (RCY61-1b  RCY90),
RCY344 (RCY90  HLK1042-1C), RCY406 (RCY327-3c  RCY344-4d),
RCY407 (RCY344-2b  RCY300-6a), RCY409 (RCY337-26a  RCY407-3a),
RCY412 (RCY278-1a  RCY407-1d), and RCY429 (JMY327-1d  RCY407-
1d). For transformations with plasmids or PCR products, we used the standard
lithium acetate-polyethylene glycol method.
Drug sensitivity assays and cell cycle analysis. Overnight cultures were serially
diluted 1:10 in water. Five microliters of the diluted cells was then spotted onto
plates containing 20 mM hydroxyurea (Sigma) or 0.01% MMS (Sigma). For the
response to antifungal agents, 100 l of itraconazole (0.1 mg/ml) (Ortho Biotech)
or fluconazole (1 mg/ml) (Pfizer) was spread on YPD plates or plates made of
synthetic media lacking histidine, as indicated. Itraconazole and fluconazole were
purchased from the University of North Carolina Hospitals Pharmacy Store-
room. Once the plates were dry, serially diluted cells were spotted on the plates.
Cells were grown for 2 to 3 days and photographed.
For cell cycle analysis, log-phase cells were arrested with 0.5 mM -factor
(Sigma) for 2 h. The cells were then centrifuged, washed once in YPD, and then
diluted in fresh YPD with or without 0.05% MMS. At the indicated time points,
1 ml of each culture was removed and fixed in 3.7% formaldehyde at room
temperature for 1 h. The cells were then centrifuged, washed once in phosphate-
buffered saline, and resuspended in 0.25 ml of phosphate-buffered saline. Bud-
ding was monitored by light microscopy. For each series shown, cells were
synchronized and released at least two separate times with the same result.
Protein analysis. Log-phase cells were centrifuged, washed once in distilled
water (dH2O) containing 1 mM phenylmethylsulfonyl fluoride, and resuspended
in sodium dodecyl sulfate-polyacrylamide gel electrophoresis loading buffer con-
taining 1 mM phenylmethylsulfonyl fluoride. The samples were then boiled for
10 min and further disrupted by mixing on a vortex mixer with an equal volume
of glass beads (Sigma). Cells were vortexed three times for 1 min each with 1 min
intervening at 0°C. Samples were then centrifuged at the maximum setting in a
microcentrifuge at 4°C. For each sample, 25 l was separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis in a 15% acrylamide gel, transferred
to HyBond C (Amersham), and probed with an antibody to the Myc (9B11; Cell
Signaling) epitope tag sequence.
Southern blot analysis. Genomic DNA was isolated from 5-ml cultures grown
in YPD or selective media overnight at 30°C. DNA purification was performed
as previously described (22). DNA was digested with PstI, separated by 1%
agarose gel electrophoresis, and transferred to HyBond N membranes (Amer-
sham). Blots were probed with a DNA fragment of the Y subtelomeric repeat,
amplified from plasmid pYT14 by PCR with the primers TELO-5 and TELO-3,
as described previously (7).
Assay for mitochondrial maintenance, canavanine resistance, membrane per-
meability, and cation pulse resistance. For assays of mitochondrial maintenance,
cells were grown on YPD plates for 2 to 3 days. Colonies were picked, suspended
in 0.5 ml of water, and diluted 104, and 100 l was plated on YPD plates. The
plates were incubated at 30°C for 2 days and then left at 4°C for 3 to 7 days, and
the numbers of red and white colonies were counted. Colonies were verified as
petite by patching at least 100 colonies on plates containing 2% glycerol as a
carbon source. For each assay, at least 15 colonies were plated, and the percent-
age of petite colonies was calculated for each plate and averaged.
Canavanine resistance assays were performed as previously described (10).
Briefly, overnight cultures were diluted in water and plated onto plates lacking
arginine, with or without 60 mg of L-canavanine (Sigma) per liter. Twenty
independent cultures were analyzed in two separate assays. The rate of canava-
nine resistance was calculated by using the method of the median (32).
Membrane permeability assays were performed essentially as described pre-
viously (2). Yeast cultures were grown to a density of 5  107 cells/ml and
incubated at various temperatures for 5 min, and crystal violet (Sigma) (prein-
cubated to the same temperature as the culture) was added to a final concen-
tration of 5 g/ml. Cells were then incubated at various temperatures for 10 min
and centrifuged, and the dye concentration in the supernatant was measured by
optical density (OD) at 595 nm. The percent crystal violet uptake was calculated
by subtracting the absorbance of cell supernatants from the absorbance of the
starting solution and then dividing by the absorbance of the starting solution.
To assay resistance to a cation pulse, yeast cultures were grown to an OD of
1, and 1 ml of cells was removed and centrifuged. Cell pellets were mixed with
50 l of a 2 M solution of CaCl2, CrCl3, KCl, MgCl2, or NiCl2 (all were
purchased from Sigma) and incubated at 30°C for 10 min. Cells were then
TABLE 1. Strains
Strain Relevant genotype Reference
W303 a ade2-1 can1-100 his3-11,15 leu2-3,112 rad5-535 trpI-1 ura3-1 52
HLK1042-1C  CAN1 hom3-10 RAD5
JMY327-1d  RAD53-13myc (::KanMX)
RCY23 tel1::ura3 VL-TEL-URA3 8




RCY93-7c Wild type a
RCY269-3d mec1-21 RAD5 XVL-TEL-URA3 9
RCY278-1a  mec1-21 RAD5 tel1::KanMX XVL-TEL-URA3 9
RCY300-6a  dun1-100::HIS3 RAD5 XVL-TEL-URA3 (listed incorrectly as scs2::HIS3 in reference 9) 9
RCY307-4a CAN1 RAD5 rad9::KanMX 10
RCY327-3c hom3-10 RAD5 rad9::KanMX 10
RCY344-2b CAN1 dap1::LEU2 RAD5 VL-TEL-URA3
RCY344-4d  dap1::LEU2 RAD5
RCY406-1d RAD5 rad9::KanMX
RCY406-5a dap1::LEU2 RAD5 rad9::KanMX
RCY407-1d CAN1 dap1::LEU2 RAD5
RCY407-3a  CAN1 dap1::LEU2 dun1::HIS3 RAD5 XVL-TEL-URA3
RCY407-12d RAD5
RCY409-2a Wild type a
RCY409-4b  CAN1 dap1::LEU2 RAD5
RCY409-5c  CAN1 dun1::HIS3 RAD5 XVL-TEL-URA3
RCY429-1a  RAD5
RCY429-1d dap1::LEU2 RAD5 RAD53-13myc (::KanMX)
RCY429-2b  RAD5 RAD53-13myc (::KanMX)
SPY40 tel1::URA3 42
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centrifuged, resuspended in phosphate-buffered saline, and plated for viability on
YPD plates. All assays were performed in triplicate and duplicated in a separate
analysis.
Sterol analysis. To determine the percentage of total cellular mass repre-
sented by sterol, quantitative sterol analysis was performed as described by
Molzahn and Woods (39). Briefly, cells were grown in YPD to an OD at 660 nm
of 0.8 to 0.9. Cells were pelleted, washed once with dH2O, and then resuspended
in 10 ml of alcoholic KOH (4.5 M KOH in 60% ethanol) and transferred to a
clean round-bottom flask. The suspension was allowed to reflux at 88 to 90°C for
60 min. One milliliter of 95% ethanol was added down the condensor, refluxing
was continued for another 60 min, and then the apparatus was cooled to room
temperature. The condensor was removed, and 4 ml of dH2O and 10 ml of
n-heptane (Sigma) were added to the flask before shaking vigorously for 2.5 min.
Two milliliters of the n-heptane layer (containing sterol) was transferred to a
clean vial, and 3 l of sample was analyzed by gas chromatography as described
below. To calculate the percentage of sterols per milligram of cell mass, 20 ml of
the original culture was harvested by vacuum filtration onto a preweighed 0.45-
m-pore-size Millipore filter. The filters were predried in a 105°C oven overnight
and subsequently placed in a dessiccator for 4 h. After vacuum filtration of
harvested cells, the heating-desiccation step was repeated, and the weight of the
cells was determined. The amount of individual sterols was calculated based on
the area under each peak of the chromatograph relative to a known amount of
ergosterol loaded onto the gas chromatograph, using the Hewlett-Packard sterol
quantitation program. Each sample was injected twice, and the value reported
for each sterol quantity was the average of those for two injections.
Sterols were analyzed by gas chromatography with a Hewlett-Packard HP5890
series II chromatograph equipped with the Hewlett-Packard CHEMSTATION
software package. The capillary column (DB-1; J&W Scientific) was pro-
grammed from 195 to 280°C (1 min at 195°C and then an increase at 20C°/min
to 240°C, followed by an increase at 2°C/min until the final temperature of 280°C
was reached). The linear velocity was 30 cm/s, nitrogen was the carrier gas, and
all injections were run in the splitless mode.
RESULTS
Identification of DAP1. YPL170W is a 456-bp open reading
frame encoding a 152-amino-acid protein with a predicted
molecular mass of 16.7 kDa. There is little homology between
the YPL170W open reading frame and other yeast open read-
ing frames, except for a 52-amino-acid region with 39% iden-
tity with the anaphase checkpoint protein Pds1p (not shown).
However, YPL170W contains strong homology with a group of
proteins that is collectively called the MAPR family (Fig. 1A).
The rat and human homologues of YPL170W resemble the
YPL170W open reading frame in size and contain homology to
YPL170W throughout their coding sequences. The MAPR
family includes 25-Dx (37, 46), the human 25-Dx homologues
Hpr6.6 and Dg6 (20) (Fig. 1B), and uncharacterized family
members in S. pombe, A. thaliana (Fig. 1B), and Caenorhabditis
elegans.
We deleted the entire YPL170W open reading frame by
one-step transplacement with the LEU2 gene. The following
sections describe the phenotypes associated with loss of
YPL170W function: damage sensitivity, telomere elongation,
partial loss of ergosterol synthesis, and defects in mitochon-
drial biogenesis. Because YPL170W mutants are damage
sensitive and YPL170W contains homology to the MAPR fam-
ily, we propose the name DAP1 (for damage response protein
related to the membrane-associated progesterone receptor)
for YPL170W.
Cells lacking DAP1 are sensitive to MMS. As part of our
characterization of dap1 mutants, we tested the ability of
dap1 strains to grow in the presence of damaging agents. We
found that dap1 strains were unable to grow on plates con-
taining 0.01% MMS (Fig. 2, middle panel, second row). The
sensitivity of dap1 strains to MMS was completely reversed by
a single-copy plasmid containing the entire DAP1 open reading
frame.
The dap1 strains were only mildly sensitive to the ribonu-
cleotide reductase inhibitor hydroxyurea, with reduced growth
at 20 mM (Fig. 2, lower panel, second row). This dose of
hydroxyurea was toxic to cells lacking the Dun1p damage re-
pair protein (Fig. 2, lower panel, bottom row). UV light and
gamma irradiation had no effect on growth of haploid dap1
strains, even at doses that killed checkpoint mutant strains.
However, diploid dap1 strains were approximately 10-fold
more sensitive to ionizing and UV radiation than a comparable
diploid wild-type strain, suggesting that Dap1p contributes to
the growth response to radiation in diploid cells.
We surmised that MMS sensitivity in dap1 strains might be
due to a checkpoint defect. Yeast cells arrested in G1 delay
budding when damaged (47), and this budding checkpoint is
MEC1 dependent (48). We synchronized log-phase wild-type
and dap1 strains in G1 with -factor and then released the
cells from G1 arrest and followed progression of the cell cycle
by analyzing budding morphology. Both wild-type and dap1
strains delayed budding when released into media containing
MMS (Fig. 3A), suggesting that the cell cycle checkpoint is
intact in dap1 cells. In contrast, mec1-21 cells did not delay
budding under similar conditions (Fig. 3A).
We examined a molecular end point for the cell cycle check-
point, monitoring the phosphorylation of the Rad53p check-
point protein kinase. Following treatment with MMS, Rad53p
becomes hyperphosphorylated (44, 51), and this phosphoryla-
tion is dependent on an intact Mec1p/Tel1p pathway (44). We
used a strain with 13 copies of the Myc epitope tag integrated
at the 3 end of the genomic copy of RAD53; the epitope-
tagged Rad53p was readily detectable in strains harboring the
integrated tag (Fig. 3B, lanes 3 to 6) but was undetectable in
cells harboring the native RAD53 allele (Fig. 3B, lanes 1 and
2). Treatment of wild-type cells with 0.05% MMS resulted in a
marked increase in Rad53p phosphorylation, as expected (Fig.
3B, compare lanes 3 and 4), and the same shift in mobility was
detected in dap1 cells (Fig. 3B, compare lanes 5 and 6). Thus,
Dap1p is not required for Rad53p hyperphosphorylation fol-
lowing treatment with MMS. Using two separate criteria, we
conclude that Dap1p is not required for the MMS-initiated cell
cycle checkpoint.
Next, unsynchronized wild-type or dap1 cells were treated
with MMS and cell cycle progression was determined by mi-
croscopic analysis of budding and by flow cytometry. We found
that dap1 cells frequently develop an aberrant shmoo mor-
phology when arrested with -factor (R. J. Craven, unpub-
lished observations). However, these elongated shmoo-shaped
cells resembled budded cells, making the early stages of the
cell cycle difficult to distinguish, so we resorted to analysis of
unsynchronized cells.
In unsynchronized log-phase cultures, the cell cycle profiles
of wild-type and dap1 cells were similar. Following 2 h of
MMS treatment, the vast majority of wild-type cells had small
to medium-sized buds (Fig. 4A), while dap1 cultures began to
accumulate unbudded cells (Fig. 4B). The difference in unbud-
ded cells between wild-type and dap1 cells following 3 h of
MMS treatment was significant (P  0.002) when analyzed by
the Student t test. Failure to bud indicates an arrest in the G1
phase of the cell cycle. Although the G1-arrested cells failed to
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grow, they were not dead, because they excluded the dead-cell
marker phloxine B.
One explanation for the accumulation of dap1 cells in G1
following MMS exposure is that Dap1p is required for adap-
tation to MMS exposure. Following prolonged damage, cells
can override cell cycle arrest and continue to grow, a process
called adaptation (54). If Dap1p is required for adaptation to
a checkpoint, we expected that loss of Dap1p in combination
with loss of checkpoint function would suppress the G1 arrest.
To test this idea, we constructed a strain lacking both DAP1
and the RAD9 checkpoint gene, and we found that dap1
rad9 cells had an even stronger G1 arrest than either single
mutant (Fig. 4C). We conclude that loss of Dap1p function
inhibits cell cycle progression in G1 following MMS-induced
damage and that this arrest is not due to an inability to adapt
to the Rad9p-mediated checkpoint.
Dap1p regulates telomere length. A number of genes re-
quired for damage repair also regulate telomere length. We
analyzed the telomeres of dap1 strains by Southern blotting.
Telomeres in the dap1 mutant were elongated by approxi-
mately 100 bp compared to those in wild-type strains (Fig. 5,
lane 3). While there was a small effect on telomere length in
dap1 strains, telomeric silencing in dap1 strains was unaf-
fected.
Tel1p is a high-molecular-weight protein kinase related to
the human Atm protein, and Tel1p is a central regulator of
telomere length. To test whether DAP1 and TEL1 are in the
same genetic pathway, we compared telomere lengths of
dap1 tel1 double mutants with those of the single dap1 and
tel1 mutants. A combined dap1 tel1 mutant had telomeres
that were slightly longer than those of the comparable tel1
strain (Fig. 5, compare lanes 2 and 4). In general, combined
mutations in two genes in the same genetic pathway result in a
phenotype of one or the other single mutant. Because the
dap1 tel1 phenotype was not intermediate between those of
the dap1 and tel1 single mutants, we conclude that TEL1 is
epistatic to DAP1 and that they function in the same genetic
pathway.
Cells lacking DAP1 are sensitive to drugs inhibiting sterol
synthesis. Microarray analyses demonstrated altered expres-
sion of the DAP1 transcript either in strains with repressed
ERG11 expression or in strains treated with the ergosterol
inhibitor itraconazole (26). ERG11 encodes lanosterol C-14
demethylase (29), a key enzyme in ergosterol synthesis. Erg11p
is inhibited by azole compounds, which inhibit Erg11p by form-
ing a complex with the heme iron component in the cyto-
chrome group (Fig. 6) (55, 58). In addition, the homology
FIG. 2. Dap1p regulates the response to MMS-induced damage. Log-phase cells were diluted 1:10 and spotted onto YPD plates (upper panel),
YPD plates containing 0.01% MMS (middle panel), or YPD plates containing 20 mM hydroxyurea (HU) (lower panel). The strains tested were
wild-type (RCY409-2a, top rows), dap1 (RCY409-4b, second rows), and dun1 (RCY409-5c, third rows). Strains harboring the dap1 mutation grew
poorly on hydroxyurea and did not grow on plates containing MMS. The dun1 strain RCY409-5c is included as a damage-sensitive control strain.
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between Dap1p and known steroid binding proteins (Fig. 1)
suggested that Dap1p might regulate sterol synthesis in yeast.
We tested the ability of dap1 mutants to grow on itracon-
azole by directly applying the drug to the surfaces of YPD
plates, allowing them to dry, then spotting series of 10-fold
dilutions to the plates. Wild-type cells grew readily on plates
coated with 0.1 mg of itraconazole per ml, while dap1 mu-
tants did not (Fig. 6B, middle panel, top two rows). Itracon-
azole sensitivity is not a general property of damage check-
point mutants, because rad9 mutants grow readily on
itraconazole. Interestingly, a mec1-21 mutant strain was mod-
erately sensitive to itraconazole, although the reason for this is
unclear, as no sterol synthetic phenotypes have been attributed
to mec1 mutants. A second Erg11p inhibitor, fluconazole, was
also toxic to dap1 strains (Fig. 6B, lower panel, middle row).
Partial loss of sterol synthesis in dap1 mutants. Because
dap1 cells were sensitive to itraconazole, we analyzed the
profile of sterols in dap1 cells by gas chromatography. In
dap1 cells, we detected a 9% decrease in overall sterol con-
centrations, with a 5% decrease in ergosterol and 43 and 34%
decreases in the ergosterol intermediates zymosterol and fe-
costerol, respectively (Fig. 7). In addition, the ergosterol inter-
mediate 4,4-dimethylzymosterol was undetectable in dap1
cells but was present at 3.3% in wild-type cells. In contrast,
there was a 17.5% increase in squalene and a 4.7-fold elevation
in the ergosterol intermediate lanosterol (eluting at 17.948 min
in Fig. 7B). For these analyses, each sample was injected twice
and the value reported for each sterol quantity was the average
of two injections. Lanosterol metabolism is the target of the
azole inhibitors itraconazole and fluconazole. We conclude
that dap1 strains have a partial lesion in sterol synthesis that
leads to decreases in products downstream of Erg11p (lanos-
terol-14-demethylase).
Membrane permeability in dap1 strains. Loss of ergosterol
synthesis can lead to elevated membrane permeability. Mu-
tants lacking the ERG6 gene have a 35-fold increase in uptake
of crystal violet compared to wild-type strains at low temper-
atures, although the elevation is modest at 30°C (2). We ex-
amined whether the sensitivity of dap1 strains to MMS could
be due to altered membrane permeability. In principal, ele-
FIG. 3. Dap1p does not regulate the damage checkpoint in MMS-treated cells. (A) Wild-type (wt) (RCY409-2a), dap1 (dap) (RCY407-1d),
or mec1-21 (mec) (RCY269-3d) cells were synchronized in the G1 phase of the cell cycle with -factor and then released in the presence or absence
of 0.05% MMS. Samples of cells were taken at various time points and fixed, and the number of budded cells were counted at each time point.
(B) Rad53p phosphorylation after treatment with MMS is not Dap1p dependent. Rad53p was fused in frame with 13 copies of the Myc epitope
tag and crossed into the dap1 mutant background. Wild-type and mutant cells were then analyzed by Western blotting with an anti-Myc antibody
before (lanes 1, 3, and 5) and after (lanes 2, 4, and 6) treatment with MMS. The strains analyzed were RAD53 DAP1 (RCY429-1a) (lanes 1 and
2), RAD53-Myc DAP1 (RCY429-2b) (lanes 3 and 4), and RAD53-Myc dap1 (RCY429-1d) (lanes 5 and 6).
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vated membrane permeability could lead to increased local
concentrations of MMS, causing a greater loss of viability than
in wild-type strains.
Wild-type and dap1 strains were grown to log phase and
incubated with 5 g of crystal violet per ml at four different
temperatures. The cells were then centrifuged, and the con-
centration of crystal violet in the supernatant was measured
and compared with the beginning concentration to calculate
uptake. Surprisingly, dap1 cells had a decreased crystal violet
uptake relative to wild-type strains at each of the temperatures
analyzed (Table 2), ranging from 1.3- to 13-fold lower than in
the wild type. Our levels of uptake for the wild-type strain
W303 were similar to those reported previously for the wild-
type strain A184D at each of the temperatures analyzed (2). At
all temperatures tested, the uptake of crystal violet in dap1
strains was significantly lower than that in wild-type cells, sug-
gesting alterations in the endocytic pathway or transmembrane
diffusion in dap1 mutants. To test whether dap1 strains are
defective in uptake of compounds other than crystal violet
from the media, we plated wild-type and dap1 strains on
plates containing the selective drug Geneticin. Both wild-type
and dap1 strains were sensitive to Geneticin, indicating that
under physiological conditions, dap1 strains are capable of
transporting compounds to the interior of the cell.
We then measured the sensitivity of dap1 strains to a cat-
ionic pulse. Cells were exposed to 2 M solutions of the chloride
salts of calcium, chromium, potassium, magnesium, and nickel
for 10 min and then plated for viability. Mutants with hyper-
permeable membranes are sensitive to a pulse of cations at
high concentrations (2). We found that the response of dap1
strains to these five cations was indistinguishable from that of
wild-type strains (Table 3). We conclude that the altered sterol
composition of dap1 strains does not disrupt the function of
the cell membrane and does not allow a major influx of dyes or
salts. Thus, it is unlikely that dap1 strains are sensitive to
MMS purely because of overly permeable membranes, in con-
trast to phenotypes associated with the erg6 mutation.
Dap1p regulates mitochondrial maintenance. Mutant
dap1 cells have elevated levels of petite colony formation
(Table 4). The W303 strain background contains the ade2
mutation, which causes a red colony color due to the accumu-
lation of adenine precursors. Cells that have lost the ability to
respire grow as small white colonies and are inviable on plates
containing a nonfermentable carbon source such as glycerol
(12). Plate cultures of dap1 isolates contained increased num-
bers of small, white colonies. We measured the frequency with
which these white colonies emerge in the population and found
that dap1 strains have a 4.4-fold elevation in petite formation
(19.6%, compared to 4.5% for the wild-type strain [Table 4]).
Thus, Dap1p is required for wild-type levels of mitochondrial
maintenance. The elevated level of petite formation may be
due to the partial arrest of ergosterol synthesis in dap1 strains,
because other ergosterol mutants, such as erg3 and erg6 mu-
tants, have elevated petite formation (45; M. Bard, unpub-
lished observations).
Petite colony formation is also characteristic of strains with
mutations within RNR genes (13). Dun1p is required for tran-
scriptional activation of RNR genes in response to damage
(59), and dun1 mutants are damage sensitive, have elevated
rates of petite formation (16) and mitotic recombination (15),
and have diminished telomeric silencing (8). We used a dun1
strain as a positive control for elevated petite colony forma-
tion, and as expected, dun1 strains had an elevated level of
petite colonies (Table 4).
These results suggest that Dap1p regulates mitochondrial
stability. Petite colonies can arise through loss of mitochon-
drial biogenesis or through mutations in nuclear genes re-
quired for mitochondrial maintenance. Thus, it was possible
that dap1 strains lose mitochondria because of an elevated
mutation frequency in the nuclear genome. We measured the
FIG. 5. DAP1 regulates telomere length. Southern blot analysis of
telomere lengths in the strains RCY93-7c (wild type) (lane 1), RCY23
(tel1) (lane 2), RCY93-4c (dap1) (lane 3), and RCY93-2a (dap1 tel1)
(lane 4) is shown. In all cases, DNA was purified according to standard
protocols, digested with PstI, blotted, and probed with a labeled frag-
ment of the Y subtelomeric repeat. Migration of molecular size stan-
dards is indicated to the left.
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rate of mutation at the CAN1 locus in dap1 strains in dupli-
cate assays of 20 independent cultures. We did not detect a
significant elevation in mutation frequency in dap1 cells com-
pared to wild-type strains (2.8  107 in dap1 cells versus 2.4
 107 in wild-type cells) (10).
DISCUSSION
We have found that the Dap1p protein is required for the
damage response, telomere length maintenance, mitochon-
drial biogenesis, and sterol regulation. Mutants lacking Dap1p
are particularly sensitive to the methylating agent MMS. MMS
methylates DNA, causing the replication fork to stall during S
phase, leading to double-stranded DNA breaks. Following cell
cycle arrest and repair of the broken DNA, the cell cycle
resumes. Our data indicate that yeast requires Dap1p in order
to progress through the G1-S phase transition following MMS-
induced damage.
Another interpretation of these data is that MMS induces a
second type of damage aside from induction of double-
stranded DNA breaks and that Dap1p is required for the G1-S
transition following this type of damage. One potential second-
ary type of damage could arise from MMS-induced oxidative
stress, which is associated with MMS (19). We pursued the
possibility that MMS-induced oxidative stress might cause cell
cycle arrest by damaging the cellular pool of sterols. Thus, the
requirement for Dap1p to exit G1 might be related to the
“sparking” requirement for ergosterol, in which diminished
ergosterol levels prevent the G1-S transition (11). To test this
idea, we treated wild-type cells for 3 h with various doses of
itraconazole and then plated the cells on MMS. Surprisingly,
itraconazole pretreatment had no effect on damage respon-
siveness in wild-type cells. This suggests that decreased sterol
synthesis coupled with MMS-induced damage does not lead to
an irreversible G1 arrest.
Cells exposed to chronic damage arrest and repair the dam-
age. If the damage persists, cells attempt to override the arrest
checkpoint in a process called adaptation (54). Our results
indicate that it is unlikely that Dap1p functions by overriding a
Rad9p-mediated G1 checkpoint. We prefer a model in which
Dap1p performs an essential function in the G1-S transition
following MMS-induced damage. The molecular function of
Dap1p in exiting G1 after damage is not clear. However,
Dap1p binds indirectly to a network of proteins that regulate
cell cycle progression and the G1-S phase transition (25). We
propose that protein interactions between Dap1p and its bind-
ing partners are required for the G1-S phase transition follow-
ing MMS-induced damage.
We have shown that Dap1p is required for wild-type ergos-
terol levels. Ergosterol is a key component of the yeast cell
membrane and resembles cholesterol structurally. Ergosterol
levels regulate membrane fluidity and permeability, endocyto-
FIG. 6. Dap1p is required for growth in response to inhibitors of ergosterol synthesis. (A) The ergosterol biosynthetic pathway, with the step
inhibited by itraconazole and fluconazole indicated. (B) Itraconazole and fluconazole inhibit the growth of dap1 strains. Wild-type (RCY407-12d,
top rows), dap1 (RCY407-1d, middle rows), and rad9 (RCY307-4a, bottom rows) strains were diluted 1:10 serially and spotted on YPD plates
without drug (upper panel) or layered with itraconazole (middle panel) or fluconazole (lower panel).
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sis, secretion, vacuole fusion, mitochondrial respiration, oxy-
gen sensing, gene expression (50), and a cell cycle sparking
function (reviewed in reference 11). We have demonstrated
that dap1 strains are sensitive to azole inhibitors of ergosterol
synthesis and have increased levels of sterol intermediates.
However, dap1 mutants are distinct from erg mutants in that
dap1 is not a sterol auxotroph, and dap1 mutants are capable
of synthesizing ergosterol, albeit at reduced levels compared to
the wild type.
Proteins that direct the synthesis of ergosterol have been
previously implicated in damage repair. Deletion of the ERG3
FIG. 7. Dap1p regulates sterol synthesis in yeast. Gas chromatography sterol accumulation profiles in the wild-type (RCY409-2a) (A) and dap1
(RCY409-4b) (B) strains from the same genetic cross are shown. The peaks for squalene (sq), zymosterol (zy), ergosterol (erg), lanosterol (la),
and 4,4-dimethylzymosterol (dz) are indicated. Loss of Dap1p led to an increase in squalene and lanosterol and a decrease in zymosterol and
ergosterol.
TABLE 2. Membrane permeability in dap1 cells determined by
crystal violet uptake
Strain
Uptakea at the following temp (°C):
0 22 30 37
Wild type (RCY409-2a) 6.5 	 0.8 24.9 	 2.4 23.6 	 1.3 31.8 	 0.8
dap1 (RCY409-2b) 0.5 	 0.5b 16.2 	 2.1b 18.1 	 1.0b 25.3 	 1.4b
a Crystal violet uptake was measured as described by Bard et al. (2) and in
Materials and Methods. Cells were incubated with crystal violet for 10 min at the
various temperatures and centrifuged. The A595 of the supernatant (Af) was
measured and compared with the absorbance of the starting solution (Ai); per-
cent uptake equals (Ai  Af)/Ai. The results from four separate reactions were
averaged, and the standard deviation is shown.
b Significantly different from the result for the wild-type strain by the Student
t test (P 
 0.05).
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gene, encoding C-5 sterol desaturase, leads to MMS sensitivity,
and erg28 and arv1 strains are MMS sensitive, but to a lesser
extent (3). In addition, erg6 mutants are sensitive to the che-
motherapeutic agents dactinomycin and doxorubicin (24). It is
likely that some of these strains are sensitive to MMS because
of increased membrane permeability (2), increasing the effec-
tive concentration of damaging agent in the cell. However, we
found that dap1 strains do not have elevated membrane per-
meability by two separate assays, indicating that the deficiency
of dap1 strains in damage repair goes beyond simple changes in
membrane structure. Interestingly, loss of ergosterol synthesis
has been linked to decreased endocytosis in some mutants
(23), consistent with the decreased uptake of crystal violet in
dap1 cells.
Mutants lacking Dap1p are defective in mitochondrial mi-
togenesis. We propose that this phenotype is due to abnormal
ergosterol synthesis in dap1 cells. The relationship between
ergosterol synthesis and mitochondrial regulation is poorly un-
derstood, because ergosterol is not a major constituent of
mitochondrial membranes relative to other membranes. How-
ever, several ergosterol synthetic mutants have decreased mi-
tochondrial function, including erg3 (45) and erg6 (unpublished
observation) strains. In addition, overexpression of the mito-
chondrial COX3 gene confers resistance to azole compounds
(31), further suggesting a link between altered respiration and
ergosterol regulation.
Dap1p is homologous to the MAPR family. The term
MAPR is based on the properties of individual family mem-
bers, because only one member is a known membrane protein
and only one has probable progesterone binding activity. The
porcine MAPR was isolated biochemically from liver mem-
brane extracts based on its binding to tritiated progesterone
(37, 14). A rat homologue of MAPR, called 25-Dx, was cloned
at the same time in a phage display screen for elevated tran-
scripts in rat liver following treatment with 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin (46). Following treatment, expression of
25-Dx was elevated three- to sevenfold (46), suggesting a role
in the response to dioxin, a potent carcinogen. A murine
MAPR homologue (also called 25-Dx) was subsequently
cloned based on its reduced expression during lordosis, a fe-
male rodent mating behavior, and its negative regulation by
progesterone (30). Green fluorescent protein-tagged murine
25-Dx localized to the cell periphery (30), and a number of
MAPR family members have putative membrane-spanning se-
quences near their amino termini. The homology between
Dap1p and membrane-associated progesterone binding pro-
teins is consistent with a similar localization for Dap1p. Be-
cause MAPR proteins are putative progesterone binding pro-
teins, we examined the toxicity of progesterone to strains
lacking Dap1p but detected no difference between dap1 and
wild-type cells with respect to progesterone-mediated toxicity.
Dap1p is the first member of the MAPR family to be directly
linked to the response to damage and sterol synthesis. Some of
these functions are probably conserved in other organisms.
DAP1 homologues are present in many model organisms, in-
cluding budding and fission yeasts, Drosophila, C. elegans, Ara-
bidopsis, and mice. Our results also indicate that an improved
understanding of this gene family may lead to novel ap-
proaches for antifungal compounds or strategies to increase
the efficacy of existing antifungal agents.
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